Barclays Downgrades Ambev to Equal-Weight, Lowers Price Target to $3
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Theurer downgraded Ambev (NYSE:ABEV) from Overweight to Equal-Weight and reduced the price target from $3.5 to $3, indicating a more cautious outlook on the stock.
March 04, 2024 | 10:55 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Barclays downgraded Ambev from Overweight to Equal-Weight and lowered the price target from $3.5 to $3, reflecting a more conservative view on the company's stock.
The downgrade by Barclays from Overweight to Equal-Weight, along with a reduction in the price target, suggests a less optimistic view on Ambev's future stock performance. This could lead to a negative short-term impact on the stock price as investors adjust their expectations based on the new analyst rating and price target.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100